Using data from 18,016 kidney transplant recipients in the United States from 2013 to 2020, the study found that those prescribed GLP-1 receptor agonists post-transplant experienced a 49% reduction in death-censored graft loss and a 31% decrease in all-cause mortality compared with nonusers
Novo also bought a biologics plant in Czech Republic from Novavax in 2024, adding further capacity (though Novo stated that site will not be used for semaglutide products)
Round up for priming losses, dropped syringes, and protocol adjustments
This formulation embodies an emerging paradigm in regenerative biology researchthat carefully selected peptide combinations can achieve synergistic effects far exceeding those of individual components by simultaneously activating multiple complementary pathways essential for tissue repair and regeneration
Diabetes Care 42 , 200207 (2019)
Summary: GLP-1 medications do not directly affect periods, but the significant weight loss they cause can indirectly influence menstrual regularity through hormonal and metabolic changes